Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age12-48
SponsorAssiut University
About this trial
To compare the efficacy of the pre-operative nebulization of a combination of dexmedetomidine and ketamine versus nebulization of dexmedetomidine alone for sedation and prevention of emergence delirium in children undergoing cleft palate repair surgeries.
Eligibility criteria
Qualifiers
Patients with American Society of Anesthesiologists (ASA) physical status I & II who will be scheduled for cleft palate repair surgeries
Disqualifiers
Parent refusal
Allergy to the study drugs
Suspected difficult airway
Patients with endocrine, renal, hepatic, and cardiac pathology
Trial design
Treatments tested in this trial
- Nebulization of dexmedetomidine and ketamine
- Nebulization of dexmedetomidine
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov